•  
  •  
  •  
  •  

2026-02-19 11:39:52

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Team24 Consumer Products Ltd enters into contract with Milk Union at Ambala
  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • RNIT AI Solutions Ltd receives pilot work order from Government of Meghalaya
  • Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India
  • HUL to invest up to ₹2,000 Crore in capacity expansion for Premium Categories

Keywords Selected:  ClinicalTrial

Stock Report

  • Phase III Clinical Trial of DengiAll® by ICMR and Panacea Biotec - Completion of enrollment of study participants
  • Suven Life Sciences achieved 100% Patient Enrolment Milestone in Phase-2b Clinical Trial of Ropanicant for Major Depressive Disorder
  • Suven Life Sciences announces First Patient Randomized in Phase-2b Clinical Trial of Ropanicant
  • Indian Regulatory Authority - SEC approval for conducting Phase III Clinical trials for Recombinant Human Albumin (rHA) 20%
  • Zydus and ICMR initiate a Phase 2 proof-of-concept trial of Desidustat in patients with Sickle Cell Disease
  • Shilpa's CDMO customer reported positive results from pivotal clinical trial & placed binding purchase order
  • CuraTeQ Biologics announces positive result in phase 3 clinical trial for its proposed Trastuzumab Biosimilar product
  • TCS ADD™ Connected Clinical Trials Wins the India Pharma Award 2022
  • Suven Life Sciences announces Randomization of First Patient in Phase-3 Global Clinical Trial of Masupirdine
  • Zydus announces Phase IV DREAM-CKD trial of Desidustat in patients with CDK induced anemia
  • Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
  • TCS Launches Risk-Based Monitoring Solution that Transforms Clinical Operational Analytics and Enhances Study Quality
  • Glenmark Specialty S.A. receives approval for conducting Phase 1 Clinical Trial of its Novel Molecule GRC 54276
  • Sun Pharma Presents Phase 3 Data for WINLEVI® (clascoterone) cream 1% for the Topical Treatment of Acne Vulgaris at the AAD Annual Meeting

Latest Post

  • Team24 Consumer Products Ltd enters into contract with Milk Union at Ambala
  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • RNIT AI Solutions Ltd receives pilot work order from Government of Meghalaya
  • Dr. Reddy's forays into Hormone Replacement Therapy segment with acquisition of Progynova® and Cyclo- Progynova® in India
  • HUL to invest up to ₹2,000 Crore in capacity expansion for Premium Categories


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025